- Home
- SON vs INDV Comparison
SON vs INDV Comparison
Compare SON & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SON | INDV |
|---|---|---|
| Founded | 1899 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.1B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SON | INDV |
|---|---|---|
| Price | $53.86 | $31.93 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $63.00 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 05-20-2026 | 06-08-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | 510.30 | ★ 8100.00 |
| EPS | ★ 10.07 | 1.64 |
| Revenue | ★ $7,518,753,000.00 | $1,239,000,000.00 |
| Revenue This Year | $0.27 | N/A |
| Revenue Next Year | $1.94 | N/A |
| P/E Ratio | ★ $5.47 | $19.59 |
| Revenue Growth | ★ 41.72 | 4.29 |
| 52 Week Low | $38.65 | $8.65 |
| 52 Week High | $58.44 | $38.00 |
Technical Indicators
Market Signals| Indicator | SON | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 40.02 |
| Support Level | $43.81 | $31.70 |
| Resistance Level | $58.44 | $32.42 |
| Average True Range (ATR) | 1.67 | 1.32 |
| MACD | -0.41 | -0.22 |
| Stochastic Oscillator | 39.19 | 31.01 |
Price Performance
Historical ComparisonAbout SON Sonoco Products Company
Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.